EUVIMEDEUVIMED entdecken
Kohortenstudie

Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study

Judy K Qiang, Rinku Sutradhar, Karl Everett, Antoine Eskander, Iliana C Lega, Afshan Zahedi, Lorraine Lipscombe

Thyroid® · 2025

DOI: 10.1089/thy.2024.0330 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Thyroid®, 2025. Verfasst von Judy K Qiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Neoplasm Recurrence, Local, Thyrotropin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Levothyroxine to suppress thyrotropin (TSH) to 2 to ≤4 mIU/L (adjusted cause specific [cs] hazard ratio [HR] 0.99 [confidence interval or CI 0.97–1.02]) but was significantly increased with each additional 3 months of exposure to TSH >4 mIU/L (adjusted csHR 1.07 [CI 1.04–1.09]). Results were similar across baseline treatment groups.

Conclusion

There was no difference in clinically significant recurrence in those with low-risk DTC maintained with a TSH of 0.5–2 mIU/L compared with 2–4 mIU/L. Guidelines should consider liberalizing target TSH level post thyroidectomy in low-risk cohorts. These results cannot be applied to patients with high-risk DTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsNeoplasm Recurrence, LocalThyrotropinHumansFemaleRetrospective StudiesMaleMiddle AgedThyroidectomyAdultAgedOntarioThyroxineIodine Radioisotopes

Stichwörter der Autor:innen

population-based studyrecurrencethyroid cancerthyrotropin target

Substanzen

ThyrotropinThyroxineIodine Radioisotopes

Autor:innen und Institutionen

  • Division of Endocrinology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Department of Otolaryngology-Head & Neck Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.

Zitieren

APA

Qiang, J. K., Sutradhar, R., Everett, K., Eskander, A., Lega, I. C., Zahedi, A., & Lipscombe, L. (2025). Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study. Thyroid®. https://doi.org/10.1089/thy.2024.0330

Vancouver

Qiang JK, Sutradhar R, Everett K, Eskander A, Lega IC, Zahedi A, et al. Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study. Thyroid®. 2025. doi:10.1089/thy.2024.0330

BibTeX
@article{Qiang2025,
  author = {Qiang, Judy K and Sutradhar, Rinku and Everett, Karl and Eskander, Antoine and Lega, Iliana C and Zahedi, Afshan and Lipscombe, Lorraine},
  title = {Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study},
  journal = {Thyroid®},
  year = {2025},
  doi = {10.1089/thy.2024.0330}
}
Kostenlos starten →